TELA Bio Inc (NAS:TELA)
$ 6 0.18 (3.09%) Market Cap: 147.93 Mil Enterprise Value: 147.58 Mil PE Ratio: 0 PB Ratio: 10.34 GF Score: 59/100

Q2 2020 TELA Bio Inc Earnings Call Transcript

Aug 12, 2020 / 08:30PM GMT
Release Date Price: $13.13 (-0.53%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Second Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to Mr. Stuart Henderson, Vice President, Corporate Development and Investor Relations for TELA Bio. Sir, the floor is yours.

Stuart M. Henderson
TELA Bio, Inc. - VP of Corporate Development & IR

Thank you, Joanna, and good afternoon, everyone. Earlier today, TELA Bio released financial results for the quarter ended June 30, 2020. A copy of the press release is available on the company's website.

Joining me on today's call are Tony Koblish, President and CEO; and Nora Brennan, CFO. Before we begin, I'd like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. We encourage you to review the company's past and future filings with the SEC, including, without limitation, the company's Form 10-K filed on March 30, 2020, and 10-Q filed on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot